Valeant Nixes CEO's $29.8 Million Stock Award in Pay Overhaul

Yahoo Finance Video

Valeant Pharmaceuticals International Inc. plans to kill a $29.8 million stock award it gave Chief Executive Officer Joseph Papa as the company revamps its compensation program for senior managers.

Scroll to continue with content
Ad

What to Read Next